RxDoctor Payments Data

Hoe le, MD

Family Medicine · Santee, CANPI 1811945611

Payments from drug & device makers

$4,358in general payments, 2019–2025

Across 324 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$407
  • GSK$369
  • Pfizer$333
  • AstraZeneca$287
  • Kowa Pharmaceuticals America, Inc.$203
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$4,30199%
  • Education$571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,358 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$63,921
Medicare patients
212
Services billed
890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin119$134,981
EliquisApixaban61$69,470
JanuviaSitagliptin Phosphate64$47,552
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$42,877
XareltoRivaroxaban25$30,438
AptiomEslicarbazepine Acetate12$28,980
FarxigaDapagliflozin Propanediol21$26,378
LinzessLinaclotide18$14,991
OzempicSemaglutide16$14,706
MyrbetriqMirabegron14$12,689
LivaloPitavastatin Calcium16$11,965
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$11,734
Atorvastatin Calcium651$5,067
Entecavir15$4,922
Albuterol Sulfate HfaAlbuterol Sulfate167$4,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$39$134,981119 claims
PfizerEliquis$333$69,47061 claims
GSKTrelegy Ellipta, Anoro Ellipta$369$54,61169 claims
MerckJanuvia$14$47,55264 claims
Johnson & JohnsonXarelto$17$30,43825 claims
AstraZenecaFarxiga, Nexium$287$29,73434 claims
Sunovion Pharmaceuticals Inc.Aptiom$162$28,98012 claims
AbbVieLinzess$1,504$14,99118 claims
Novo NordiskOzempic$185$14,70616 claims
Astellas Pharma US IncMyrbetriq$45$12,68914 claims
Kowa Pharmaceuticals America, Inc.Livalo$203$11,96516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Santee

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →